COFCO Biotechnology Co., Ltd. (SHE:000930)
China
· Delayed Price · Currency is CNY 5.47
-0.06 (-1.08%)
Apr 2, 2025, 1:45 PM CST
COFCO Biotechnology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 20,467 | 20,064 | 19,619 | 23,560 | 19,257 | 18,902 | Upgrade
|
| Other Revenue | 314.46 | 314.46 | 299.42 | - | 652.13 | 569.75 | Upgrade
|
| Revenue | 20,782 | 20,379 | 19,918 | 23,560 | 19,909 | 19,472 | Upgrade
|
| Revenue Growth (YoY) | 5.26% | 2.31% | -15.46% | 18.33% | 2.25% | 9.99% | Upgrade
|
| Cost of Revenue | 19,918 | 19,798 | 17,837 | 21,122 | 18,089 | 16,856 | Upgrade
|
| Gross Profit | 863.28 | 581.4 | 2,081 | 2,437 | 1,821 | 2,616 | Upgrade
|
| Selling, General & Admin | 832.73 | 789.39 | 807.17 | 814.69 | 798.78 | 1,809 | Upgrade
|
| Research & Development | 158.96 | 165.28 | 132.86 | 119.28 | 113.67 | 87.15 | Upgrade
|
| Other Operating Expenses | 44.63 | 46.61 | -386.92 | -181.36 | 109.04 | 125.46 | Upgrade
|
| Operating Expenses | 1,034 | 1,001 | 553.32 | 752.82 | 1,021 | 2,022 | Upgrade
|
| Operating Income | -170.73 | -419.74 | 1,527 | 1,684 | 799.23 | 593.41 | Upgrade
|
| Interest Expense | -105.07 | -112.78 | -87.12 | -157.79 | -94.32 | -162.12 | Upgrade
|
| Interest & Investment Income | 73.44 | 38.77 | 16.24 | 55.51 | 10.58 | 45.47 | Upgrade
|
| Currency Exchange Gain (Loss) | 10.85 | 10.85 | 65.92 | -1.22 | -3.33 | 2.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.46 | -6.76 | -15.06 | 15.08 | -14.31 | -8.13 | Upgrade
|
| EBT Excluding Unusual Items | -192.97 | -489.66 | 1,507 | 1,596 | 697.86 | 471.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | -50.57 | -32.93 | -4.26 | 1.86 | -23.54 | 0.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.32 | 1.16 | -145.82 | -203.22 | -13.98 | -699.46 | Upgrade
|
| Asset Writedown | 42.5 | -54.45 | -13.3 | -21.48 | -27.07 | -8.65 | Upgrade
|
| Other Unusual Items | -0.24 | -0.24 | 5.25 | -5.18 | 164.7 | 902.43 | Upgrade
|
| Pretax Income | -172.01 | -542.54 | 1,360 | 1,377 | 801.95 | 666.33 | Upgrade
|
| Income Tax Expense | 77.22 | 73.75 | 299.28 | 247.88 | 173.75 | 107.46 | Upgrade
|
| Earnings From Continuing Operations | -249.23 | -616.29 | 1,061 | 1,130 | 628.2 | 558.87 | Upgrade
|
| Minority Interest in Earnings | -9.93 | 14.66 | -2.08 | 0.09 | -35.08 | 33.95 | Upgrade
|
| Net Income | -259.16 | -601.63 | 1,059 | 1,130 | 593.12 | 592.82 | Upgrade
|
| Net Income to Common | -259.16 | -601.63 | 1,059 | 1,130 | 593.12 | 592.82 | Upgrade
|
| Net Income Growth | - | - | -6.29% | 90.45% | 0.05% | 22.73% | Upgrade
|
| Shares Outstanding (Basic) | 1,854 | 1,842 | 1,857 | 1,844 | 1,848 | 1,847 | Upgrade
|
| Shares Outstanding (Diluted) | 1,854 | 1,842 | 1,857 | 1,849 | 1,852 | 1,847 | Upgrade
|
| Shares Change (YoY) | 0.94% | -0.85% | 0.45% | -0.18% | 0.27% | -0.56% | Upgrade
|
| EPS (Basic) | -0.14 | -0.33 | 0.57 | 0.61 | 0.32 | 0.32 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.33 | 0.57 | 0.61 | 0.32 | 0.32 | Upgrade
|
| EPS Growth | - | - | -6.71% | 90.79% | -0.22% | 23.42% | Upgrade
|
| Free Cash Flow | 335.01 | 1,323 | 142.66 | 3,732 | -3,898 | 2,749 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.72 | 0.08 | 2.02 | -2.10 | 1.49 | Upgrade
|
| Dividend Per Share | - | - | 0.570 | 0.245 | 0.065 | 0.016 | Upgrade
|
| Dividend Growth | - | - | 132.65% | 276.92% | 306.25% | -36.00% | Upgrade
|
| Gross Margin | 4.15% | 2.85% | 10.45% | 10.35% | 9.14% | 13.43% | Upgrade
|
| Operating Margin | -0.82% | -2.06% | 7.67% | 7.15% | 4.01% | 3.05% | Upgrade
|
| Profit Margin | -1.25% | -2.95% | 5.31% | 4.79% | 2.98% | 3.04% | Upgrade
|
| Free Cash Flow Margin | 1.61% | 6.49% | 0.72% | 15.84% | -19.58% | 14.12% | Upgrade
|
| EBITDA | 309.22 | 42.89 | 1,967 | 2,119 | 1,236 | 1,019 | Upgrade
|
| EBITDA Margin | 1.49% | 0.21% | 9.88% | 9.00% | 6.21% | 5.23% | Upgrade
|
| D&A For EBITDA | 479.95 | 462.63 | 439.53 | 434.94 | 436.4 | 425.28 | Upgrade
|
| EBIT | -170.73 | -419.74 | 1,527 | 1,684 | 799.23 | 593.41 | Upgrade
|
| EBIT Margin | -0.82% | -2.06% | 7.67% | 7.15% | 4.01% | 3.05% | Upgrade
|
| Effective Tax Rate | - | - | 22.01% | 18.00% | 21.67% | 16.13% | Upgrade
|
| Revenue as Reported | 20,782 | 20,379 | 19,918 | 23,560 | 19,909 | 19,472 | Upgrade
|
| Advertising Expenses | - | 3.04 | 2.81 | 2.68 | 4.13 | 10.36 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.